0

Pulmonary Hypertension Collection
 1-20 of 48 Articles
Articles |  21 October 2008
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized Trial
Gérald Simonneau, MD; Lewis J. Rubin, MD; Nazzareno Galiè, MD; et al.
Ann Intern Med. 2008;149(8):521-530. doi:10.7326/0003-4819-149-8-200810210-00004
Editorials |  21 October 2008
Therapy for Pulmonary Arterial Hypertension: The More, the Merrier?
Darren B. Taichman, MD, PhD
Ann Intern Med. 2008;149(8):583-585. doi:10.7326/0003-4819-149-8-200810210-00010
Reviews |  19 February 2008
Narrative Review: The Enigma of Pulmonary Arterial Hypertension: New Insights from Genetic Studies
John H. Newman, MD; John A. Phillips, MD; James E. Loyd, MD
Ann Intern Med. 2008;148(4):278-283. doi:10.7326/0003-4819-148-4-200802190-00006
Reviews |  16 August 2005
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
Lewis J. Rubin, MD; David B. Badesch, MD
Ann Intern Med. 2005;143(4):282-292. doi:10.7326/0003-4819-143-4-200508160-00009
Articles |  2 April 2002
Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension
Hossein Ardeschir Ghofrani, MD; Ralph Wiedemann, MD; Frank Rose, MD; et al.
Ann Intern Med. 2002;136(7):515-522. doi:10.7326/0003-4819-136-7-200204020-00008
Articles |  21 March 2000
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease: A Randomized, Controlled Trial
David B. Badesch, MD; Victor F. Tapson, MD; Michael D. McGoon, MD; et al.
Ann Intern Med. 2000;132(6):425-434. doi:10.7326/0003-4819-132-6-200003210-00002
Articles |  21 March 2000
Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial
Horst Olschewski, MD; H. Ardeschir Ghofrani, MD; Thomas Schmehl, PhD; et al.
Ann Intern Med. 2000;132(6):435-443. doi:10.7326/0003-4819-132-6-200003210-00003
Editorials |  21 March 2000
Epoprostenol (Prostacyclin) and Pulmonary Hypertension
Alfred P. Fishman, MD
Ann Intern Med. 2000;132(6):500-502. doi:10.7326/0003-4819-132-6-200003210-00013
Brief Communications |  4 May 1999
Compassionate Use of Continuous Prostacyclin in the Management of Secondary Pulmonary Hypertension: A Case Series
Vallerie V. McLaughlin, MD; Diane E. Genthner, RN, BSN; Maureen M. Panella, RN, BSN; et al.
Ann Intern Med. 1999;130(9):740-743. doi:10.7326/0003-4819-130-9-199905040-00014
Brief Communications |  16 March 1999
Pulmonary Hypertension after Splenectomy?
Marius M. Hoeper, MD; Jost Niedermeyer, MD; Frank Hoffmeyer, MD; et al.
Ann Intern Med. 1999;130(6):506-509. doi:10.7326/0003-4819-130-6-199903160-00014
Brief Communications |  1 December 1996
Pulmonary Hypertension Developing after Alglucerase Therapy in Two Patients with Type 1 Gaucher Disease Complicated by the Hepatopulmonary Syndrome
Arthur Dawson, MD; Darlene J. Elias, MD; David Rubenson, MD; et al.
Ann Intern Med. 1996;125(11):901-904. doi:10.7326/0003-4819-125-11-199612010-00005
Brief Communications |  1 May 1996
Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension
Horst Olschewski, MD; Dieter Walmrath, MD; Ralph Schermuly, PhD; et al.
Ann Intern Med. 1996;124(9):820-824. doi:10.7326/0003-4819-124-9-199605010-00006
Reviews |  1 June 1995
The Eosinophilia-Myalgia Syndrome: Status of 205 Patients and Results of Treatment 2 Years after Onset
Phillip A. Hertzman, MD; Daniel J. Clauw, MD; Lee D. Kaufman, MD; et al.
Ann Intern Med. 1995;122(11):851-855. doi:10.7326/0003-4819-122-11-199506010-00008
Articles |  15 September 1994
Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin
Robyn J. Barst, MD; Lewis J. Rubin, MD; Michael D. McGoon, MD; et al.
Ann Intern Med. 1994;121(6):409-415. doi:10.7326/0003-4819-121-6-199409150-00003
Editorials |  15 September 1994
Prostacyclin and Primary Pulmonary Hypertension
Stuart Rich, MD
Ann Intern Med. 1994;121(6):463-464. doi:10.7326/0003-4819-121-6-199409150-00012
Brief Reports |  1 July 1993
Hypothyroidism and Primary Pulmonary Hypertension: An Autoimmune Pathogenetic Link?
David B. Badesch, MD; Kristine M. Wynne, RN, BSN; Scott Bonvallet, MD; et al.
Ann Intern Med. 1993;119(1):44-46. doi:10.7326/0003-4819-119-1-199307010-00008
Articles |  1 June 1992
Pulmonary Hypertension Predicts Mortality and Morbidity in Patients with Dilated Cardiomyopathy
Sandra V. Abramson, MD; James F. Burke, MD; John J. Kelly, MD; et al.
Ann Intern Med. 1992;116(11):888-895. doi:10.7326/0003-4819-116-11-888
Articles |  1 September 1991
Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry
Gilbert E. D'Alonzo, DO; Robyn J. Barst, MD; Stephen M. Ayres, MD; et al.
Ann Intern Med. 1991;115(5):343-349. doi:10.7326/0003-4819-115-5-343
Articles |  15 March 1991
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Duncan J. Stewart, MD; Robert D. Levy, MD; Peter Cernacek, MD; et al.
Ann Intern Med. 1991;114(6):464-469. doi:10.7326/0003-4819-114-6-464
Articles |  1 April 1990
Treatment of Primary Pulmonary Hypertension with Continuous Intravenous Prostacyclin (Epoprostenol): Results of a Randomized Trial
Lewis J. Rubin, MD; Jessica Mendoza, BSN; Michele Hood, BSPh; et al.
Ann Intern Med. 1990;112(7):485-491. doi:10.7326/0003-4819-112-7-485
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)